Summary
A multi-phase study was undertaken to compare the metabolic effect on unstable Type 1 diabetic patients of optimized conventional treatment with that of external or implantable insulin delivery devices. External units were programmed to simulate implantable constant basal rate insulin infusion pumps with additional insulin doses given by subcutaneous injection or delivered by the pump. The study was continued using external devices with an optimal, meal-adjusted insulin profile simulating programmable, remote-controlled, implantable devices. Such good metabolic control was achieved using the constant insulin infusion, supplemented by two subcutaneous injections of insulin daily, that it justified the implantation of constant rate pumps in five Type 1 patients. Patients with the implanted devices achieved a near-normal life style, experienced significantly fewer hypoglycaemic reactions and had significantly improved glycosylated haemoglobin A1 and mean blood glucose values.
Article PDF
Similar content being viewed by others
References
Irsigler K, Kritz H (1979) Long-term continuous intravenous insulin therapy with a portable insulin dosage-regulating apparatus. Diabetes 28: 196–203
Irsigler K, Kritz H, Kaspar L, Braendle J, Koller W, Franetzki M (1978) Preprogrammed insulin infusion with a portable pump system. In: Hepp KD, Kerner W, Pfeiffer EF (eds) Proceedings of feedback controlled and preprogrammed insulin infusion in diabetes mellitus. Workshop Reisensburg, FRG. Georg Thieme, Stuttgart New York, pp 193–197
Irsigler K, Kunz NK, Owens DR, Regal N (1980) New approaches to insulin therapy. MTP Press, Lancaster
Irsigler K, Kritz H (1980) Zur klinischen Anwendung der Insulin-infusion im open-loop System. Gesamte Inn Med l: 8–19
Irsigler K, Kritz H (1980) Alternate routes of insulin delivery. Diabetes Care 3: 219–228
Irsigler K, Kritz H (1982) Improvement of insulin therapy for diabetics through pump treatment. In: Peterson CM (ed) Diabetes management in the 80's. Praeger Publishers, New York, pp 218–234
Kritz H, Irsigler K (1982) Continuous open loop infusion. Comparison of IV and SC insulin infusion with SC conventional treatment in unstable Jod's. In: Federlin K, Pfeiffer EF, Raptis S (eds) Islet-pancreas transplantation and artificial pancreas. Georg Thieme, Stuttgart New York, pp 297–300
Editorial (1980) Subcutaneous injections and absorption of insulin. Lancet 1: 1005–1006
Spencer WJ (1981) A review of programmed insulin delivery systems. Trans Biomed Engin 28: 237–251
Blackshear PJ, Rohde TD, Prosl F, Buchwald H (1979) The implantable infusion pump: a new concept in drug delivery. Med Progr Techn 6: 149–161
Buchwald H, Rohde TD, Dorman F, Skakoon J, Wigness B, Prosl F, Tucker E, Rublein T, Blackshear PJ, Varco R (1980) A totally implantable drug infusion device: laboratory and clinical experience using a model with single flow rate and new design for modulating insulin infusion. Diabetes Care 3: 351–358
Buchwald H, Varco R, Rupp WM, Goldberg FJ, Barbosa J, Rohde TD, Schwartz RA, Rublein T, Blackshear PJ (1981) Treatment of a Type 2 diabetic by a totally implantable insulin device. Lancet 1: 1233–1235
Irsigler K, Kritz H, Hagmüller G, Franetzky M, Prestele K, Thurow H, Geisen K (1981) Long-term continuous intraperitoneal insulin infusion with an implanted remote-controlled infusion device. Diabetes 30: 1072–1075
Kritz H, Hagmüller G, Buchwald H, Denck H, Najemnik C, Irsigler K (1983) Constant basai rate infusion of insulin with an implanted drug infusion device in insulin dependent maturity-onset diabetics. In: Brunetti P (ed) International symposium on artificial systems for insulin delivery, Assisi, September 1981. Raven Press, New York (in press)
Hagmüller G (1983) Implantation of insulin delivery devices. In: Irsigler K, Kritz H, Lovett R (eds) Diabetes treatment with implantable infusion systems. Urban and Schwarzenberg, Munich Vienna Baltimore (in press)
Blackshear PJ, Dorman FD, Blackshear Jr PL, Varco RL, Buchwald H (1970) A permanently implantable self recycling low flow constant rate multi-purpose infusion pump of simple design. Surg Forum 21:136–138
Rupp WM, Barbosa JJ, Blackshear PJ, McCarthy HB, Rohde TD, Goldenberg FJ, Rublein TG, Dorman FD, Buchwald H (1982) The use of an implantable insulin pump in the treatment of Type II diabetes. N Engl J Med 307: 265–270
Schade DS, Eaton RP (1980) The peritoneum — A potential insulin delivery route for mechanical pancreas. Diabetes Care 3:229–234
Marliss EB, Caron D, Albisser AM, Zinman B (1981) Present and future expectations regarding insulin infusion systems. Diabetes Care 4: 325–327
Waldhaeusl W, Bratusch-Marrain P, Gasic S, Korn A, Nowotny P (1979) Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia 17:221–227
Knatterud G (1983) First report from implant registration system. In: Irsigler K, Kritz H, Lovett R (eds) Diabetes treatment with implantable infusion systems. Urban und Schwarzenberg, Munich Vienna Baltimore (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kritz, H., Hagmüller, G., Lovett, R. et al. Implanted constant basal rate insulin infusion devices for type 1 (Insulin-dependent) diabetic patients. Diabetologia 25, 78–81 (1983). https://doi.org/10.1007/BF00250891
Issue Date:
DOI: https://doi.org/10.1007/BF00250891